Nomogram based on tumor-associated neutrophil-to-lymphocyte ratio to predict survival of patients with gastric neuroendocrine neoplasms

Table 2 Characteristics of 142 patients with gastric neuroendocrine neoplasms with different levels of tumor-associated neutrophil-to-lymphocyte ratios

Patient feature	TA-NLR		Univariate analysis
	≤ 0.21(n = 71)	> 0.21(n = 71)	P value
Symptom
Abdominal pain	46	41	0.390
Dysphagia	14	12	0.665
Nausea	12	9	0.480
Vomiting	5	5	1.000
Acid-reflux	9	4	0.156
Anemia	10	13	0.495
Abdominal distention	6	8	0.575
Gastrointestinal blood loss	12	14	0.665
Weight loss	24	29	0.386
No symptoms	2	7	0.105
Medical history
Hypertension	19	15	0.432
Diabetes	7	3	0.202
Coronary heart disease	4	4	1.000
Chronic gastritis	44	38	0.796
Family history	5	6	0.754
Smoking	26	27	0.862
Drinking	6	4	0.515

TA-NLR: Tumor-associated neutrophil-to-lymphocyte ratio.